BioElectronics Corporation (BIEL) Research

BioElectronics Corporation, also known by its ticker BIEL, operates as an electroceutical firm dedicated to creating and marketing innovative wearable neuromodulation devices worldwide. The company's core mission is to mitigate neurological ailments and enhance the well-being of individuals globally through its advanced technology. Its diverse product lineup includes ActiPatch, a treatment for musculoskeletal discomfort; Allay, designed to alleviate menstrual pain; and Smart Insole, which targets heel pain. Furthermore, BioElectronics offers RecoveryRx, a specialized medical device providing pain management solutions for healthcare professionals. They also provide HealFast, a non-pharmacological therapy for animals such as horses, cats, and dogs, effective in reducing swelling and pain, and promoting the healing of muscle and tendon injuries, wounds, and surgical incisions. The company distributes its products through a multi-channel approach, reaching wholesale distributors, hospitals and clinics, and directly to consumers. BioElectronics Corporation was established in the year 2000 and has its principal offices situated in Frederick, Maryland.

Open BioElectronics Corporation (BIEL) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.